<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Nail disorders in infants and children: Acquired nail diseases
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Nail disorders in infants and children: Acquired nail diseases
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Nail disorders in infants and children: Acquired nail diseases
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Bianca Maria Piraccini, MD, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michela Starace, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Moise L Levy, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 21, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1101763534">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nail disorders in children can be broadly classified as congenital/inherited or acquired. The latter include trauma-induced, infectious, and inflammatory disorders, and tumors. They are benign in most cases but may be a cause of concern for parents and caregivers [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
         This topic will discuss the clinical features, diagnosis, and treatment of the most common acquired nail disorders in children. Congenital and inherited nail disorders in children are discussed separately. An overview of nail disorders in adults, nail surgery, and nail biopsy are also discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/126518.html" rel="external">
          "Nail disorders in children: Congenital and hereditary nail diseases"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13682.html" rel="external">
          "Overview of nail disorders"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13709.html" rel="external">
          "Nail biopsy: Indications and techniques"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/16202.html" rel="external">
          "Principles and overview of nail surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H210159850">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nail disorders are relatively uncommon in children, accounting for approximately 3 to 11 percent of pediatric dermatology consultations [
         <a href="#rid3">
          3,4
         </a>
         ]. Data on the prevalence of specific nail disorders in pediatric populations are lacking. In one study, the prevalence of onychomycosis among patients attending a pediatric dermatologic clinic was 1.1 percent [
         <a href="#rid5">
          5,6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2317674274">
         <span class="h1">
          ANATOMY OF THE NAIL UNIT IN CHILDREN
         </span>
         <span class="headingEndMark">
          —
         </span>
         Understanding nail anatomy is key to the recognition and management of nail diseases  (
         <a class="graphic graphic_picture graphicRef85578" href="/z/d/graphic/85578.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13682.html" rel="external">
          "Overview of nail disorders", section on 'Anatomy and physiology of the nail unit'
         </a>
         .)
        </p>
        <p>
         In newborns, the nails are thin and soft but completely formed. The normal fingernails are oval or rectangular in shape, with a longitudinal major axis, and flat. In many cases, the lunula is not visible. The toenails often have a trapezoid shape, with the distal width greater than the proximal.
        </p>
        <p>
         The growth of the nail plate is continuous throughout life. The growth rate increases throughout infancy, peaks at the age of 10 to 14 years, and then becomes similar to that of young adults (1 to 1.5 mm/day) [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3370942014">
         <span class="h1">
          TRAUMA-INDUCED NAIL DISORDERS
         </span>
        </p>
        <p class="headingAnchor" id="H4171196782">
         <span class="h2">
          Finger sucking, nail biting, onychotillomania
         </span>
         <span class="headingEndMark">
          —
         </span>
         In newborns, nail changes, including thinning and pterygium (extension and adherence of the proximal nail fold to the nail bed secondary to scarring of the nail matrix), can occur secondary to the formation of sucking blisters on the dorsal surface of fingers in utero [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5790.html" rel="external">
          "Vesicular, pustular, and bullous lesions in the newborn and infant", section on 'Sucking blisters'
         </a>
         .)
        </p>
        <p>
         In young children and adolescents, nail biting (onychophagia) is common. It is estimated that over 30 percent of children older than seven years and 45 percent of adolescents are nail biters [
         <a href="#rid1">
          1,10
         </a>
         ].
        </p>
        <p>
         Clinical findings resulting from chronic nail biting include dystrophic nail changes, damage of periungual tissues, distal ingrowing of the nail plate, and progressive nail shortening [
         <a href="#rid11">
          11
         </a>
         ]. Complications include acute paronychia, bacterial and viral infections, and intraoral injuries and infections [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
         Onychotillomania (nail picking disorder) is characterized by repeated picking or manicuring of the nails that results in shortening and dystrophy of the nail plate. (See
         <a class="medical medical_review" href="/z/d/html/13698.html" rel="external">
          "Skin picking (excoriation) disorder and related disorders", section on 'Nail picking disorder'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1126884696">
         <span class="h2">
          Punctate leukonychia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Punctate leukonychia (white spots on the nail plate) is typically seen in toddlers and young children. It is due to mild, traumatic injury to the distal matrix, which results in defective keratinization of the nail plate [
         <a href="#rid8">
          8
         </a>
         ]. The white spots correspond to clusters of parakeratotic cells (keratinocytes with retained nucleus) within the nail plate, which alter the light reflection properties of the nail.
        </p>
        <p>
         Punctate leukonychia resolves spontaneously without treatment as the nail grows.
        </p>
        <p class="headingAnchor" id="H1147018183">
         <span class="h2">
          Retronychia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Retronychia is an uncommon disorder of the great toenail characterized by the ingrowth of the proximal nail plate into the proximal nail fold and the stacking of multiple generations of nail plates beneath the proximal nail fold  (
         <a class="graphic graphic_picture graphicRef132188" href="/z/d/graphic/132188.html" rel="external">
          picture 2
         </a>
         ) [
         <a href="#rid13">
          13,14
         </a>
         ]. Although predominantly described in adults, retronychia has also been reported in children younger than 12 years and adolescents [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
         Retronychia is caused by a continued, usually minor trauma to the toenail that interrupts the continuity between the nail matrix and the nail plate. In contrast with onychomadesis, where the new nail growing from the matrix pushes the old nail plate forward (which is ultimately shed), in retronychia, the new nail pushes the old one upward and backward, interrupting the longitudinal growth of the nail. Several nail plates pile up under the proximal nail fold, resulting in inflammation and formation of granulation tissue. Pain and difficulty in walking are commonly reported symptoms.
        </p>
        <p>
         Nail avulsion provides definitive treatment. However, conservative treatment with high-potency topical corticosteroids for several weeks is a reasonable initial treatment in children [
         <a href="#rid15">
          15-19
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2952888367">
         <span class="h1">
          INFLAMMATORY DISEASES
         </span>
        </p>
        <p class="headingAnchor" id="H860244136">
         <span class="h2">
          Nail psoriasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nail involvement has been reported in approximately 15 to 60 percent of children with psoriasis and is generally unrelated to the type of psoriasis, duration, or severity [
         <a href="#rid20">
          20-25
         </a>
         ]. Occasionally, nail lesions may be the sole manifestation of the disease. (See
         <a class="medical medical_review" href="/z/d/html/110152.html" rel="external">
          "Psoriasis in children: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation and diagnosis
         </strong>
         – Nail lesions generally appear at the age of 7 to 12 years. Changes are usually mild and frequently go unnoticed. In very young children, a gradual thickening of one of several toenails may be a presenting sign  (
         <a class="graphic graphic_picture graphicRef131752" href="/z/d/graphic/131752.html" rel="external">
          picture 3
         </a>
         ). In older children, common nail abnormalities include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pitting
         </strong>
         – Mild pitting of fingernails is the most common sign, occurring in up to 90 percent of affected children. Psoriatic pits are typically large and irregular in shape and distribution  (
         <a class="graphic graphic_picture graphicRef131749" href="/z/d/graphic/131749.html" rel="external">
          picture 4
         </a>
         ). Pitting is usually limited to one or a few digits, and it is only rarely associated with other signs of nail psoriasis [
         <a href="#rid21">
          21,26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Onycholysis
         </strong>
         – Onycholysis, often associated with subungual hyperkeratosis, is the second most common sign of nail psoriasis in children  (
         <a class="graphic graphic_picture graphicRef131751" href="/z/d/graphic/131751.html" rel="external">
          picture 5
         </a>
         ). It typically involves several nails and is an important diagnostic clue. The salmon-pink, erythematous border ("oil drop sign"  (
         <a class="graphic graphic_picture graphicRef66374" href="/z/d/graphic/66374.html" rel="external">
          picture 6
         </a>
         )) that usually surrounds the onycholytic area in psoriasis may be absent or scarcely visible in children.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Trachyonychia
         </strong>
         – Trachyonychia ("rough nails") or twenty-nail dystrophy  (
         <a class="graphic graphic_picture graphicRef113140" href="/z/d/graphic/113140.html" rel="external">
          picture 7
         </a>
         ) may be a sign of nail psoriasis in children [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Splinter hemorrhages
         </strong>
         – Splinter hemorrhages are common and are favored by trauma [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnosis is straightforward in children with typical nail changes, especially in those who also have skin manifestations of psoriasis. In patients with subtle, isolated onycholysis, nail dermoscopy (onychoscopy), which allows for the examination of the nail with high magnification, can be helpful for detecting subclinical signs of nail psoriasis. As an example, enlarged, twisted capillaries in the nail bed, similar to those seen in cutaneous psoriatic plaques, appear as red dots on examination with a handheld dermatoscope  (
         <a class="graphic graphic_picture graphicRef110041" href="/z/d/graphic/110041.html" rel="external">
          picture 8
         </a>
         ) [
         <a href="#rid28">
          28,29
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/100033.html" rel="external">
          "Dermoscopy of nonpigmented nail lesions", section on 'Differential diagnosis of onycholysis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Conditions causing onycholysis and subungual hyperkeratosis that can be confused with nail psoriasis include mainly distal subungual onychomycosis and eczema. A potassium hydroxide (KOH) preparation of subungual debris scrapings is appropriate in most patients with subungual hyperkeratosis to exclude onychomycosis. (See
         <a class="medical medical_review" href="/z/d/html/4034.html" rel="external">
          "Onychomycosis: Epidemiology, clinical features, and diagnosis", section on 'Potassium hydroxide preparation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Topical agents, including topical corticosteroids, topical calcineurin inhibitors, topical retinoids, and vitamin D analogues, are first-line treatments for nail psoriasis in children [
         <a href="#rid30">
          30
         </a>
         ].
         <a class="drug drug_pediatric" data-topicid="12822" href="/z/d/drug information/12822.html" rel="external">
          Tacrolimus
         </a>
         0.1% ointment,
         <a class="drug drug_pediatric" data-topicid="13004" href="/z/d/drug information/13004.html" rel="external">
          tazarotene
         </a>
         0.05% cream, or vitamin D analogues can be applied once daily for five days per week (eg, on weekdays) in combination with a topical corticosteroid twice weekly (eg, on weekends). Topical agents are applied at bedtime. Wearing cotton gloves at night can prevent finger sucking and the potential ingestion of topical drugs.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Intralesional steroids may be used in older children and teenagers who are cooperative [
         <a href="#rid31">
          31
         </a>
         ]. Systemic treatment may be needed in cases of refractory or severe disease. Among biologic drugs,
         <a class="drug drug_pediatric" data-topicid="13284" href="/z/d/drug information/13284.html" rel="external">
          etanercept
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13077" href="/z/d/drug information/13077.html" rel="external">
          adalimumab
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="126474" href="/z/d/drug information/126474.html" rel="external">
          ustekinumab
         </a>
         are approved for administration in children [
         <a href="#rid32">
          32
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/96391.html" rel="external">
          "Nail psoriasis", section on 'Treatment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Studies suggest that the involvement of the nails in pediatric psoriasis is an important predictor of psoriasis severity over time [
         <a href="#rid33">
          33,34
         </a>
         ].
         <strong>
         </strong>
         Whether nail psoriasis is associated with an increased risk of psoriatic arthritis in children remains uncertain. In a United States study of 181 children with plaque psoriasis, psoriatic arthritis was reported with similar frequency in children with and without nail involvement (13 and 9 percent, respectively) [
         <a href="#rid23">
          23
         </a>
         ]. In contrast, a cross-sectional French study of 313 hospitalized patients younger than 18 years with psoriasis found a higher prevalence of psoriatic arthritis in children with nail psoriasis compared with those without (7.9 versus 2.4 percent) [
         <a href="#rid20">
          20
         </a>
         ]. However, because psoriatic arthritis and nail psoriasis are both associated with more severe disease, the independent role of nail involvement as a predictor of psoriatic arthritis remains unclear.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2782978521">
         <span class="h2">
          Parakeratosis pustulosa
         </span>
         <span class="headingEndMark">
          —
         </span>
         Parakeratosis pustulosa
         <strong>
         </strong>
         is a chronic pediatric nail disorder associated with multiple inflammatory skin conditions, including psoriasis, atopic dermatitis, and contact dermatitis [
         <a href="#rid35">
          35
         </a>
         ]. It is usually limited to one digit (most often the thumb or the index finger), which shows mild, psoriasiform changes (eg, distal or lateral subungual hyperkeratosis, distal onycholysis) more marked on one side of the nail  (
         <a class="graphic graphic_picture graphicRef131767" href="/z/d/graphic/131767.html" rel="external">
          picture 9
         </a>
         ). In most patients, nail signs are associated or preceded by an acute, inflammatory episode with erythema, scaling, and vesicles of the fingertip that evolves over time to nail dystrophy.
        </p>
        <p>
         In most cases, parakeratosis pustulosa spontaneously regresses, but it may evolve into nail psoriasis.
        </p>
        <p class="headingAnchor" id="H2139529880">
         <span class="h2">
          Atopic dermatitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Atopic dermatitis involving the dorsal hands and periungual tissues  (
         <a class="graphic graphic_picture graphicRef132408" href="/z/d/graphic/132408.html" rel="external">
          picture 10
         </a>
         ) may be associated with inflammation of the nail matrix, resulting in dystrophic nail changes, most frequently transverse ridges and grooves, nail pitting, koilonychia, and trachyonychia [
         <a href="#rid36">
          36,37
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H101387012">
         <span class="h2">
          Nail lichen planus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lichen planus is an autoimmune skin disorder that may affect the skin, nails, or mucous membranes [
         <a href="#rid38">
          38
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/5662.html" rel="external">
          "Lichen planus"
         </a>
         ). Nail lichen planus occurs in approximately 14 to 20 percent of children with cutaneous lichen planus, with a male predilection [
         <a href="#rid39">
          39-42
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – Nail lichen planus typically presents with nail plate thinning with longitudinal ridging, fissuring, and distal splitting involving one or multiple nails  (
         <a class="graphic graphic_picture graphicRef131991" href="/z/d/graphic/131991.html" rel="external">
          picture 11
         </a>
         ). Occasionally, lichen planus may present in children with trachyonychia (twenty-nail dystrophy) [
         <a href="#rid43">
          43
         </a>
         ]. Nail bed involvement with mild onycholysis and subungual hyperkeratosis is another possible presentation. Dorsal pterygium (a V-shaped extension of the proximal nail fold into the nail bed, which divides the nail plate into two parts), secondary to an irreversible damage to a portion of the nail matrix, is rare in children. Permanent anonychia is also rare.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnosis of nail lichen planus is suspected based on the typical clinical findings. Onychoscopy can support the clinical diagnosis, as it enhances the visualization of the longitudinal fissures of the nail plate typical of nail lichen planus [
         <a href="#rid44">
          44-46
         </a>
         ]. However, a nail matrix biopsy is often needed to confirm the diagnosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Early treatment is recommended to prevent irreversible nail damage [
         <a href="#rid43">
          43
         </a>
         ]. The treatment approach is selected based on the age of the child, number of affected nails, severity of nail changes, and presence of concomitant lichen planus in other body areas [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In older children (&gt;14 years) and young adults with lichen planus that involves one to three nails, intralesional injections of
         <a class="drug drug_pediatric" data-topicid="12858" href="/z/d/drug information/12858.html" rel="external">
          triamcinolone
         </a>
         acetonide are the first-line treatment. They require local anesthesia and are generally well tolerated [
         <a href="#rid31">
          31
         </a>
         ]. Triamcinolone acetonide in concentrations of 2.5, 5, or 10 mg/mL, depending on disease severity, is injected monthly for five to six months to achieve visible improvement. Hematomas and transient numbness of the distal digit are common adverse events. Atrophy can be easily avoided by using an appropriate technique [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In younger children and in children with more than three nails involved, severe disease, or lichen planus involving the nail bed, intramuscular
         <a class="drug drug_pediatric" data-topicid="12858" href="/z/d/drug information/12858.html" rel="external">
          triamcinolone
         </a>
         0.5 to 1 mg/kg monthly for at least three to six months is an alternative to intralesional therapy. Oral corticosteroids may also be a treatment option, but their use is limited by the risk of adverse effects [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The efficacy of intralesional or systemic corticosteroids has not been evaluated in clinical trials. Evidence for efficacy is mainly based on small, observational studies and expert consensus [
         <a href="#rid47">
          47
         </a>
         ]. In the authors' experience, corticosteroids, either intralesional or systemic, are effective in achieving arrest of progression or total or partial regression of nail symptoms in approximately two-thirds of patients. Fingernails respond more and quicker than toenails, which may remain thicker for a long time. Unfortunately, relapses occur in approximately 60 percent of patients [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Second-line therapeutic options for patients who do not respond to systemic steroids include oral retinoids [
         <a href="#rid49">
          49,50
         </a>
         ], systemic immunosuppressors, antimalarials [
         <a href="#rid51">
          51
         </a>
         ], and
         <a class="drug drug_pediatric" data-topicid="13205" href="/z/d/drug information/13205.html" rel="external">
          dapsone
         </a>
         [
         <a href="#rid52">
          52
         </a>
         ]. However, these treatments have not been evaluated in children.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3515556108">
         <span class="h2">
          Nail lichen striatus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nail lichen striatus is rare and almost exclusively seen in children between the ages of 4 months and 15 years [
         <a href="#rid53">
          53
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13731.html" rel="external">
          "Lichen striatus"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – Nail lichen striatus typically involves one nail and presents with longitudinal ridging restricted to the medial or lateral portion of the nail plate  (
         <a class="graphic graphic_picture graphicRef95734" href="/z/d/graphic/95734.html" rel="external">
          picture 12
         </a>
         ). Other findings include longitudinal fissuring, onycholysis, and distal splitting. Cutaneous lichen striatus is usually present proximally to the involved nail, with red, pink, or skin-colored, flat-topped papules arranged in a linear band distributed along the Blaschko lines  (
         <a class="graphic graphic_picture graphicRef131772" href="/z/d/graphic/131772.html" rel="external">
          picture 13
         </a>
         ). Nail changes generally appear a few weeks after the initial skin lesions but occasionally may be the only clinical manifestation of lichen striatus [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnosis of nail lichen striatus is usually clinical. Dermoscopy can be useful to support the diagnosis, as it allows for an enhanced visualization of longitudinal ridges, fissures, and distal splitting of the nail plate and may show red spots in the lunula, corresponding to inflamed matrix areas [
         <a href="#rid55">
          55
         </a>
         ]. A nail biopsy, although not routinely performed, may be necessary if the diagnosis is in doubt (eg, multiple digits affected, lack of concurrent skin lesions).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         <strong>
          and prognosis
         </strong>
         – Due to its self-limiting course and benign nature, treatment is generally not needed. Nail changes resolve spontaneously in 6 to 12 months in most cases, but they may also last for a few years [
         <a href="#rid54">
          54,56
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a few cases, topical corticosteroids and topical calcineurin inhibitors have been beneficial for hastening the resolution [
         <a href="#rid57">
          57
         </a>
         ]. Intralesional corticosteroid injections are a possible option for long-standing, severe forms [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H838742858">
         <span class="h2">
          Alopecia areata
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nail changes occur in nearly 50 percent of children with alopecia areata and are usually associated with severe disease [
         <a href="#rid58">
          58,59
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3320.html" rel="external">
          "Alopecia areata: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – Pitting is, by far, the most common nail change in children with alopecia areata [
         <a href="#rid58">
          58
         </a>
         ]. Nail pits are typically regular in size and shape and are arranged in a geometric, grid-like pattern  (
         <a class="graphic graphic_picture graphicRef131777" href="/z/d/graphic/131777.html" rel="external">
          picture 14
         </a>
         ) [
         <a href="#rid59">
          59
         </a>
         ]. Other findings include trachyonychia (see
         <a class="local">
          'Trachyonychia'
         </a>
         below); geometric, punctate leukonychia; Beau's lines; and red lunula [
         <a href="#rid26">
          26,60
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Topical, intralesional, and systemic corticosteroids are the treatments of choice, depending on the severity of nail changes and age of the patient [
         <a href="#rid31">
          31,58
         </a>
         ]. Although nail involvement is considered a risk factor for refractory alopecia areata, the clinical outcome of nail disease may not parallel that of hair loss.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4177897981">
         <span class="h2">
          Trachyonychia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Trachyonychia ("rough nails") is caused by mild inflammation of the proximal nail matrix and is characterized by rough, brittle nails with excessive longitudinal ridging. Although trachyonychia may be associated with inflammatory skin diseases, including alopecia areata, lichen planus, atopic dermatitis, and psoriasis, it is most often idiopathic in children and follows a benign, self-limited course [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation and diagnosis
         </strong>
         – Trachyonychia may affect one, a few, or all nails ("twenty-nail dystrophy"). The affected nails typically show diffuse roughness with longitudinal and regular striations and are usually opaque with a sandpaper appearance (opaque trachyonychia  (
         <a class="graphic graphic_picture graphicRef131778" href="/z/d/graphic/131778.html" rel="external">
          picture 15
         </a>
         )). Less commonly, trachyonychia presents with diffuse, closely aggregated, small, superficial pits that reflect light, which gives the nail a shiny appearance (shiny trachyonychia) [
         <a href="#rid61">
          61
         </a>
         ]. Nail thinning with koilonychia and cuticle hyperkeratosis may be associated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnosis is usually clinical. History and/or concomitant presence of clinical signs of inflammatory skin diseases suggest the etiology. The precise diagnosis of isolated trachyonychia may require a nail matrix biopsy. However, a nail biopsy is generally not recommended due to the benignity of the disease and its good prognosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Idiopathic trachyonychia improves spontaneously over two to six years [
         <a href="#rid27">
          27
         </a>
         ]. Thus, treatment is generally not required [
         <a href="#rid27">
          27
         </a>
         ]. However, for patients who desire treatment, therapeutic options include keratolytics; topical or oral retinoids; and topical, intralesional, or oral corticosteroids.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3226705112">
         <span class="h2">
          Ingrown nails
         </span>
         <span class="headingEndMark">
          —
         </span>
         An ingrown toenail (onychocryptosis) occurs when the nail plate edge grows into the lateral nail fold, resulting in a foreign body inflammatory reaction  (
         <a class="graphic graphic_picture graphicRef132187" href="/z/d/graphic/132187.html" rel="external">
          picture 16
         </a>
         ) [
         <a href="#rid62">
          62
         </a>
         ].
        </p>
        <p>
         In infants and toddlers, ingrown nails are uncommon and usually associated with congenital hypertrophy of the lateral nail folds or congenital malalignment of the hallux nail. (See
         <a class="medical medical_review" href="/z/d/html/126518.html" rel="external">
          "Nail disorders in children: Congenital and hereditary nail diseases", section on 'Congenital hypertrophy of the lateral nail fold of the hallux'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126518.html" rel="external">
          "Nail disorders in children: Congenital and hereditary nail diseases", section on 'Congenital malalignment of the great toenail'
         </a>
         .)
        </p>
        <p>
         In adolescents and young adults, ingrown nails are the most common toenail disease, with a clear male predominance (male-to-female ratio approximately 2:1). Anatomical nail characteristics (eg, unusually wide or curved toenails) may be a predisposing factor. Triggering factors include improper nail trimming (eg, cutting away the distal lateral nail edges), tight-fitting shoes, hyperhidrosis, and trauma.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – Ingrown toenails have been classified into three clinical stages, based on clinical findings and severity [
         <a href="#rid63">
          63
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Mild (stage 1)
         </strong>
         – The lateral nail plate is embedded in one or both lateral folds, which become swollen, erythematous, and painful.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Moderate (stage 2)
         </strong>
         – Edema and erythema are complicated by secondary infection, seropurulent discharge, and formation of granulation tissue (pseudopyogenic granuloma).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Severe (stage 3)
         </strong>
         – There is chronic inflammation with epithelialized granulation tissue and severe hypertrophy of the lateral nail folds.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Conservative measures are generally recommended in cases of mild to moderate lesions. These include cotton wick insertion under the corner of the nail, dental floss technique, sleeve technique, taping procedure, and nail wiring. Surgical treatment is indicated for the most severe cases. Surgical techniques include partial nail avulsion coupled with partial surgical or chemical matricectomy, radical resection of the affected nailfold, and total nail avulsion. However, these techniques have not been evaluated in high-quality studies, and there is no consensus among experts on the technique of choice [
         <a href="#rid64">
          64
         </a>
         ]. Recurrence is common [
         <a href="#rid65">
          65
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/131356.html" rel="external">
          "Ingrown nails", section on 'Management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H298040704">
         <span class="h1">
          INFECTIOUS DISEASES
         </span>
        </p>
        <p class="headingAnchor" id="H543187970">
         <span class="h2">
          Onychomycosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Onychomycosis is uncommon in children [
         <a href="#rid5">
          5,6,66,67
         </a>
         ]. In a systematic review of 34 studies, the pooled worldwide prevalences of dermatophyte and yeast onychomycosis in children were 0.14 and 0.09 percent, respectively [
         <a href="#rid66">
          66
         </a>
         ].
         <em>
          Trichophyton rubrum
         </em>
         is the most common etiologic agent [
         <a href="#rid68">
          68,69
         </a>
         ]. Predisposing factors include male sex, concurrent tinea pedis, dermatophyte infection in other family members, nail abnormalities, traumatic factors, and immunodepression. (See
         <a class="medical medical_review" href="/z/d/html/4034.html" rel="external">
          "Onychomycosis: Epidemiology, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/105222.html" rel="external">
          "Onychomycosis: Management"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – The most common type of dermatophyte onychomycosis is distal subungual onychomycosis. It presents with onycholysis, subungual hyperkeratosis, and yellowish discoloration  (
         <a class="graphic graphic_picture graphicRef131788" href="/z/d/graphic/131788.html" rel="external">
          picture 17
         </a>
         ). Less commonly, onychomycosis may present as proximal subungual onychomycosis or white superficial onychomycosis.
         <em>
          Candida
         </em>
         species may invade the nails in predisposed children (mainly newborn or immunodepressed children), resulting in total onychomycosis with paronychia [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Laboratory tests (ie, potassium hydroxide [KOH] preparation and fungal culture) are needed to confirm the diagnosis [
         <a href="#rid70">
          70
         </a>
         ]. Nail dermoscopy (onychoscopy) can help in differentiating clinical onychomycosis from other conditions that cause onycholysis (eg, trauma, nail psoriasis) and guide the decision to perform mycology tests. Dermoscopy can also help identify the best spot to obtain adequate samples for mycologic examination [
         <a href="#rid71">
          71
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/100033.html" rel="external">
          "Dermoscopy of nonpigmented nail lesions", section on 'Differential diagnosis of onycholysis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Topical antifungal agents are the first-line treatment for limited distal subungual onychomycosis (involvement of less than 50 percent of the nail plate in one to three nails) [
         <a href="#rid72">
          72
         </a>
         ]. We typically use
         <a class="drug drug_pediatric" data-topicid="13063" href="/z/d/drug information/13063.html" rel="external">
          ciclopirox
         </a>
         8% lacquer daily or amorolfine 5% lacquer weekly for a minimum of three months [
         <a href="#rid73">
          73
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Oral antifungal therapy should be considered when more than three nails are involved and when more than 50 percent of the nail plate is involved. Among antifungal agents,
         <a class="drug drug_pediatric" data-topicid="13072" href="/z/d/drug information/13072.html" rel="external">
          terbinafine
         </a>
         has a good safety profile in children [
         <a href="#rid74">
          74
         </a>
         ]. Terbinafine is given for 8 weeks for fingernails and 12 weeks for toenails.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         There is limited evidence on the efficacy and safety of antifungal treatments for pediatric onychomycosis. Topical treatments may be preferred in children due to a favorable safety profile and consideration that a thinner nail plate and faster nail growth rate may increase the response rate.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a small, randomized trial that included 40 children with distal toenail dermatophyte onychomycosis treated with
         <a class="drug drug_pediatric" data-topicid="13063" href="/z/d/drug information/13063.html" rel="external">
          ciclopirox
         </a>
         lacquer or vehicle for 32 weeks, mycologic cure was 70 percent in the active treatment group and 20 percent in the vehicle group [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a systematic review of seven studies (one randomized trial) examining the efficacy and safety of oral antifungal treatment in children, the pooled response rate for
         <a class="drug drug_pediatric" data-topicid="13072" href="/z/d/drug information/13072.html" rel="external">
          terbinafine
         </a>
         (84 patients) and
         <a class="drug drug_pediatric" data-topicid="13396" href="/z/d/drug information/13396.html" rel="external">
          itraconazole
         </a>
         (94 patients) was 80 and 79 percent, respectively [
         <a href="#rid76">
          76
         </a>
         ]. However, the studies were generally of poor quality and used heterogeneous definitions of cure. Adverse events were rare and included increase of liver enzymes in one patient taking terbinafine and ataxia and fatigue in two patients taking itraconazole.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H812214667">
         <span class="h2">
          Viral infections
         </span>
        </p>
        <p class="headingAnchor" id="H2883501215">
         <span class="h3">
          Ungual warts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ungual warts are benign lesions caused by human papillomavirus (HPV) strains 1, 2, 4, 27, and 57. They are common in children older than six years, and their spread is facilitated by nail biting. (See
         <a class="medical medical_review" href="/z/d/html/4029.html" rel="external">
          "Cutaneous warts (common, plantar, and flat warts)"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – Warts present as small, hyperkeratotic papules that grow over time, reaching a size of up to 10 to 20 mm. They are usually located in the proximal nail folds but can also develop under the nail plate  (
         <a class="graphic graphic_picture graphicRef131807" href="/z/d/graphic/131807.html" rel="external">
          picture 18
         </a>
         ) [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnosis of warts is clinical. Onychoscopy may be helpful for detecting subclinical periungual warts that are too small to be seen by the naked eye [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Wart management is challenging due to the high rate of recurrence and risk of treatment-related nail dystrophy. Therapeutic options include
         <a class="drug drug_pediatric" data-topicid="12778" href="/z/d/drug information/12778.html" rel="external">
          topical salicylic acid
         </a>
         , cryotherapy with liquid nitrogen,
         <a class="drug drug_general" data-topicid="10296" href="/z/d/drug information/10296.html" rel="external">
          trichloroacetic acid
         </a>
         , duct tape,
         <a class="drug drug_pediatric" data-topicid="13156" href="/z/d/drug information/13156.html" rel="external">
          cimetidine
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="140771" href="/z/d/drug information/140771.html" rel="external">
          cantharidin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9786" href="/z/d/drug information/9786.html" rel="external">
          podophyllin resin
         </a>
         , and carbon dioxide (CO
         <sub>
          2
         </sub>
         ) laser [
         <a href="#rid78">
          78,79
         </a>
         ]. We typically use liquid salicylic acid as first-line treatment. (See
         <a class="medical medical_review" href="/z/d/html/4029.html" rel="external">
          "Cutaneous warts (common, plantar, and flat warts)", section on 'Salicylic acid'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Intralesional injection of
         <a class="drug drug_pediatric" data-topicid="13088" href="/z/d/drug information/13088.html" rel="external">
          bleomycin
         </a>
         is
         <strong>
          not
         </strong>
         indicated in children due to the risk of systemic absorption.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H427162388">
         <span class="h3">
          Herpetic whitlow
         </span>
         <span class="headingEndMark">
          —
         </span>
         Herpetic whitlow (herpetic paronychia) is a viral infection of the hand caused by herpes simplex virus (herpes simplex virus type 1 [HSV-1] and herpes simplex virus type 2 [HSV-2]). It typically occurs in children who suck their fingers or bite their nails and have a primary herpetic gingivostomatitis or are asymptomatic salivary carriers. (See
         <a class="medical medical_review" href="/z/d/html/15117.html" rel="external">
          "Overview of hand infections", section on 'Herpetic whitlow'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – Herpetic whitlow typically affects one finger and presents with single or grouped vesicles with clear or cloudy content close to the nail or involving the lateral nail folds  (
         <a class="graphic graphic_picture graphicRef131819" href="/z/d/graphic/131819.html" rel="external">
          picture 19
         </a>
         ). Accompanying symptoms include pain, swelling, and erythema. Nail bed location may rarely occur, with painful lateral onycholysis and subungual hemorrhage.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnosis is in most cases clinical but can be confirmed by Tzanck smear or viral culture. Onychoscopy can be useful to detect vesicles not visible to the naked eye (eg, on periungual tissues or subungual space) [
         <a href="#rid44">
          44,80
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The main differential diagnoses of herpetic whitlow are bacterial paronychia and bacterial felon [
         <a href="#rid81">
          81
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Herpetic whitlow is a benign, self-limiting disease that, in most cases, resolves without treatment in two to three weeks. Antiviral therapy (eg, oral
         <a class="drug drug_pediatric" data-topicid="13247" href="/z/d/drug information/13247.html" rel="external">
          acyclovir
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13001" href="/z/d/drug information/13001.html" rel="external">
          valacyclovir
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13294" href="/z/d/drug information/13294.html" rel="external">
          famciclovir
         </a>
         ) is indicated in children with recurrent lesions or in immunocompromised children who may develop disseminated disease. Oral antivirals should be administered within 48 to 96 hours of disease onset. (See
         <a class="medical medical_review" href="/z/d/html/6046.html" rel="external">
          "Herpetic gingivostomatitis in young children", section on 'Indications for antiviral therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4028955353">
         <span class="h3">
          Hand, foot, and mouth disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hand, foot, and mouth disease (HFMD) is a common viral disease in children that typically manifests with fever and vesicles involving the hands, feet, and mouth. The disease is most frequently associated with coxsackievirus and enterovirus infection [
         <a href="#rid82">
          82
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/96219.html" rel="external">
          "Hand, foot, and mouth disease and herpangina"
         </a>
         .)
        </p>
        <p>
         The mechanism of nail lesions is not clear but might be related to mechanical trauma (eg, finger sucking) and secondary viral infection of the nail matrix, resulting in the arrest of nail matrix proliferation [
         <a href="#rid83">
          83-85
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – The most frequent nail change observed in HFMD is onychomadesis (nail shedding) of several or all nails; it typically occurs four to eight weeks after the onset of illness [
         <a href="#rid84">
          84
         </a>
         ]. Beau lines and leukonychia have also been described [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Treatment is not required because the disease has a spontaneous regression with rare sequelae.
         <strong>
         </strong>
         Parents and caregivers can be reassured that complete regrowth of the nail will occur in 6 to 12 weeks.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H954056819">
         <span class="h2">
          Bacterial infections
         </span>
        </p>
        <p class="headingAnchor" id="H23755205">
         <span class="h3">
          Blistering distal dactylitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Blistering distal dactylitis is a rare, localized bacterial infection of the distal phalanx that most commonly affects children between 2 and 16 years of age. The causative organisms are group A
         <em>
          Streptococcus
         </em>
         , and, less commonly,
         <em>
          Staphylococcus aureus
         </em>
         and
         <em>
          Staphylococcus epidermidis
         </em>
         .
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – Blistering distal dactylitis typically presents with an oval, fluid-filled blister 10 to 30 mm in diameter located on a single finger pad  (
         <a class="graphic graphic_picture graphicRef85581 graphicRef85582 graphicRef85580" href="/z/d/graphic/85581.html" rel="external">
          picture 20A-C
         </a>
         ). Over the following days, the blister can extend to the nail folds and rupture, leaving a superficial erosion. Patients may complain of pain and a burning sensation [
         <a href="#rid87">
          87,88
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnosis is clinical and can be confirmed with Gram stain smear and bacterial culture of the blister fluid. The differential diagnosis includes herpetic whitlow, epidermolysis bullosa, bullous impetigo, and friction blisters [
         <a href="#rid89">
          89
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Tense bullae can be deflated with a sterile needle to provide pain relief and then covered with a nonadherent dressing. Empirical treatment with beta-lactamase-resistant antibiotics (eg, flucloxacillin,
         <a class="drug drug_pediatric" data-topicid="13227" href="/z/d/drug information/13227.html" rel="external">
          dicloxacillin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9288" href="/z/d/drug information/9288.html" rel="external">
          cloxacillin
         </a>
         ) can be started while awaiting the culture results. For patients with proven methicillin-resistant
         <em>
          Staphylococcus aureus
         </em>
         (MRSA) infection, oral or parenteral agents that cover local strains of MRSA are indicated [
         <a href="#rid87">
          87,90
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6027.html" rel="external">
          "Skin and soft tissue infections in children &gt;28 days: Evaluation and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H620970265">
         <span class="h3">
          Paronychia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute paronychia is a painful bacterial infection of the periungual tissues caused by
         <em>
          S. aureus
         </em>
         and group A
         <em>
          Streptococcus
         </em>
         [
         <a href="#rid91">
          91
         </a>
         ]. The inciting event is a mechanical lesion of the periungual skin, usually caused by trauma. Paronychia is also a frequent adverse event in children treated with BRAF and MEK inhibitor anticancer agents [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – Acute paronychia presents with pain, swelling, and erythema of the nail folds. Formation of pus along the paronychial fold can occasionally result in the formation of an abscess involving the hyponychium and the area below the nail plate  (
         <a class="graphic graphic_picture graphicRef132405" href="/z/d/graphic/132405.html" rel="external">
          picture 21
         </a>
         ). Due to the fragility of the nail matrix in children, even a mild, acute paronychia may induce a permanent nail dystrophy. The diagnosis of paronychia is made clinically.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Systemic antibiotics are the first-line therapy for acute paronychia without abscess in children. Empirical treatment is started with beta-lactamase-resistant antibiotics (eg, flucloxacillin,
         <a class="drug drug_pediatric" data-topicid="13227" href="/z/d/drug information/13227.html" rel="external">
          dicloxacillin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9288" href="/z/d/drug information/9288.html" rel="external">
          cloxacillin
         </a>
         ). Drainage is indicated if there is abscess [
         <a href="#rid93">
          93
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5574.html" rel="external">
          "Paronychia", section on 'Treatment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H966791714">
         <span class="h1">
          TUMORS
         </span>
        </p>
        <p class="headingAnchor" id="H603394555">
         <span class="h2">
          Subungual exostosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Subungual exostosis is a benign, solitary, slowly growing osteochondroma of the toes and fingers. It is the most common nail tumor in the pediatric population, with adolescents and young adults representing 16 to 55 percent of patients [
         <a href="#rid94">
          94
         </a>
         ]. The etiology is unknown, but patients often report a history of trauma.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – Subungual exostosis typically develops at the mediodorsal tip of the terminal phalanx, elevating the nail plate. It is palpated as a stone-hard tumor firmly attached to the bone with a keratotic surface that can occasionally ulcerate  (
         <a class="graphic graphic_picture graphicRef131994" href="/z/d/graphic/131994.html" rel="external">
          picture 22
         </a>
         ) [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Dermoscopy may support the clinical suspicion of exostosis [
         <a href="#rid44">
          44,96
         </a>
         ]. The diagnosis is confirmed by radiographic examination and histopathologic examination of the excised lesion.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The clinical differential diagnosis includes ingrown toenails, verruca vulgaris, pyogenic granulomas, glomus tumors, lipomas, fibromas, keratoacanthomas, squamous cell carcinomas, and subungual malignant melanomas [
         <a href="#rid97">
          97
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – The first-line treatment of subungual exostosis is complete surgical resection. It is important to remove the entire lesion because recurrence after excision is estimated to occur in up to 53 percent of cases [
         <a href="#rid98">
          98,99
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1011425626">
         <span class="h2">
          Fibrokeratoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acquired ungual fibrokeratoma is a benign fibroepithelial tumor of the nail apparatus of unknown etiology [
         <a href="#rid100">
          100
         </a>
         ]. Traumatic events with consequent reactive hyperplasia have been suggested as causative factors [
         <a href="#rid101">
          101
         </a>
         ]. Multiple fibrokeratomas (Koenen tumors) occur in approximately one-half of children affected by tuberous sclerosis complex and are considered a major clinical diagnostic criterion. (See
         <a class="medical medical_review" href="/z/d/html/6175.html" rel="external">
          "Tuberous sclerosis complex: Clinical features"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – Fibrokeratomas usually arise from the proximal nail fold as a pedunculated lesion with a characteristic "garlic clove" shape  (
         <a class="graphic graphic_picture graphicRef132362" href="/z/d/graphic/132362.html" rel="external">
          picture 23
         </a>
         ). They are associated with a longitudinal furrow of the nail plate due to compression of the matrix. Fibrokeratomas of the distal nail bed produce erythronychia and a subungual, filiform mass.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnosis of ungual fibrokeratoma is made based on histopathologic examination of the excised lesion.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – Surgical excision is the treatment of choice. The recurrence rate after treatment is approximately 10 percent due to the incomplete surgical removal [
         <a href="#rid99">
          99,102
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1126590585">
         <span class="h2">
          Pyogenic granuloma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pyogenic granuloma is a relatively common, acquired, benign, vascular tumor that frequently involves the nail apparatus, including the periungual tissues and the nail bed. (See
         <a class="medical medical_review" href="/z/d/html/13736.html" rel="external">
          "Pyogenic granuloma (lobular capillary hemangioma)"
         </a>
         .)
        </p>
        <p>
         The pathogenesis of pyogenic granuloma is unclear. Trauma, infection, drugs, and sex hormones associated with pregnancy are the most frequent causes. The high frequency of pyogenic granuloma around the nails is likely due to the high frequency of trauma and/or inflammation of the periungual tissues and high vascularity of the nail unit [
         <a href="#rid103">
          103
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – The lesion appears as a solitary, red, pedunculated papule that is very friable and bleeds easily. Less commonly, it may present as a sessile plaque. It shows rapid, exophytic growth over weeks and often undergoes ulceration and bleeding.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnosis is clinical in most cases. The main differential diagnosis is amelanotic melanoma of the nail apparatus, which is very rare in children.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment and prognosis
         </strong>
         – There is no consensus among experts on the treatment of periungual pyogenic granuloma in children. In children, we prefer a trial of topical beta-blockers (eg, topical
         <a class="drug drug_pediatric" data-topicid="12844" href="/z/d/drug information/12844.html" rel="external">
          timolol
         </a>
         , topical
         <a class="drug drug_pediatric" data-topicid="12744" href="/z/d/drug information/12744.html" rel="external">
          propranolol
         </a>
         ) as initial therapy [
         <a href="#rid104">
          104-106
         </a>
         ]. We instruct parents or caregivers to apply one drop of a topical beta-blocker to the lesion twice daily for two months. Lesions that do not respond to topical timolol are surgically excised [
         <a href="#rid107">
          107
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Other therapies include pulsed dye laser, cryotherapy, cautery and electrodesiccation, chemical cauterization with
         <a class="drug drug_pediatric" data-topicid="12788" href="/z/d/drug information/12788.html" rel="external">
          silver nitrate
         </a>
         , or
         <a class="drug drug_general" data-topicid="8638" href="/z/d/drug information/8638.html" rel="external">
          imiquimod
         </a>
         [
         <a href="#rid108">
          108
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13736.html" rel="external">
          "Pyogenic granuloma (lobular capillary hemangioma)", section on 'Management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H924841606">
         <span class="h2">
          Melanonychia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Melanonychia refers to a black-brown-gray pigmentation of the nail due to the presence of melanin within the nail plate. It may be due to melanocytic activation or melanocytic hyperplasia. (See
         <a class="medical medical_review" href="/z/d/html/121519.html" rel="external">
          "Longitudinal melanonychia", section on 'Melanonychia due to melanocytic activation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/121519.html" rel="external">
          "Longitudinal melanonychia", section on 'Melanonychia due to melanocytic hyperplasia'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features and diagnosis
         </strong>
         – Melanonychia in children most frequently presents as a longitudinal band (longitudinal melanonychia) but may also appear as a transversal band (transversal melanonychia) or involve the entire nail plate (total melanonychia) [
         <a href="#rid109">
          109,110
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Melanonychia affecting multiple nails
         </strong>
         – When multiple nails are affected, melanonychia may represent a normal variant in populations with highly pigmented skin (ethnic melanonychia) or may be associated with hyperpigmentation syndromes, such as Peutz-Jeghers syndrome and Laugier-Hunziker syndrome. (See
         <a class="medical medical_review" href="/z/d/html/2533.html" rel="external">
          "Peutz-Jeghers syndrome: Clinical manifestations, diagnosis, and management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/89268.html" rel="external">
          "Acquired hyperpigmentation disorders", section on 'Laugier-Hunziker syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Melanonychia affecting a single digit
         </strong>
         – In most cases, melanonychia affecting a single digit  (
         <a class="graphic graphic_picture graphicRef131995" href="/z/d/graphic/131995.html" rel="external">
          picture 24
         </a>
         ) is due to melanocyte proliferation (nail matrix nevus or, rarely, melanoma).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Nail matrix nevi
         </strong>
         – Nail matrix nevi may be present at birth, or they may develop at two to four years of age. They occur more frequently in fingernails (most often in the thumb) than in toenails. The nail shows a longitudinal, pigmented band whose width and degree of pigmentation varies considerably among patients. The pigmentation may be homogenously distributed, or darker bands may appear over diffuse, pale pigmentation [
         <a href="#rid111">
          111
         </a>
         ]. Dark bands may be associated with the pseudo-Hutchinson sign because the dark nail plate pigmentation is visible through the transparent nail fold. Some clinical and onychoscopic features that are alarming in adults are commonly observed in children: Hutchinson sign, variation of the color of the band, triangular shape, globules, and nail dystrophy [
         <a href="#rid112">
          112
         </a>
         ]. In children, it is also quite common to observe a gradual fading of the band [
         <a href="#rid113">
          113
         </a>
         ]. Fading of the pigmentation, called "regressing nevoid nail melanoma in childhood," is unique to children and not indicative of regression of the nevus but just of decreased melanocytic activity of nevus cells [
         <a href="#rid114">
          114,115
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Nail melanoma
         </strong>
         – The total number of pediatric nail melanomas described in the literature is very small and consists mainly of melanomas in situ [
         <a href="#rid116">
          116
         </a>
         ]. Clinical and dermoscopic signs that suggest melanoma in children are rapid evolution in growth and darkening of the color. In these cases, a nail matrix biopsy is essential for an accurate diagnosis [
         <a href="#rid117">
          117
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13709.html" rel="external">
          "Nail biopsy: Indications and techniques", section on 'Nail matrix biopsy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management and prognosis
         </strong>
         – The approach to treatment depends on the child's personal and family history and on the clinical and dermoscopic features of the pigmented nail band. The decision to perform a biopsy in a younger child with melanonychia is often influenced by the parents' or caregivers' anxiety. However, the benefit of potentially diagnosing a rare, subungual melanoma must be weighed against the risks associated with nail unit biopsy, including the risks of sedation, the possibility of pigment recurrence, and the possibility of permanent nail dystrophy [
         <a href="#rid26">
          26
         </a>
         ]. When surgery is chosen, tangential excision of the matrix lesion is the best option [
         <a href="#rid118">
          118
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1260098160">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Acquired nail diseases, including traumatic, inflammatory, and infectious diseases and nail tumors, are uncommon in children. Although they mirror those seen in adults in most cases, a few nail disorders are only seen in children (see
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Epidemiology'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Trauma-induced
         </strong>
         – Trauma-induced nail disorders include nail biting, onychotillomania, punctate leukonychia, and retronychia. Punctate leukonychia (white spots on the nail plate) is typically seen in toddlers and young children as a result of mild trauma to the distal nail matrix  (
         <a class="graphic graphic_picture graphicRef132188" href="/z/d/graphic/132188.html" rel="external">
          picture 2
         </a>
         ). Retronychia of the great toe (growth of the proximal nail plate into the proximal nail fold) is uncommon and can occur in older children and adolescents. (See
         <a class="local">
          'Trauma-induced nail disorders'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inflammatory diseases
         </strong>
         – Inflammatory nail diseases seen in children as well as in adults include nail psoriasis  (
         <a class="graphic graphic_picture graphicRef131752" href="/z/d/graphic/131752.html" rel="external">
          picture 3
         </a>
         and
         <a class="graphic graphic_picture graphicRef131749" href="/z/d/graphic/131749.html" rel="external">
          picture 4
         </a>
         and
         <a class="graphic graphic_picture graphicRef131751" href="/z/d/graphic/131751.html" rel="external">
          picture 5
         </a>
         and
         <a class="graphic graphic_picture graphicRef66374" href="/z/d/graphic/66374.html" rel="external">
          picture 6
         </a>
         ), nail lichen planus  (
         <a class="graphic graphic_picture graphicRef131991" href="/z/d/graphic/131991.html" rel="external">
          picture 11
         </a>
         ), nail alopecia areata  (
         <a class="graphic graphic_picture graphicRef131777" href="/z/d/graphic/131777.html" rel="external">
          picture 14
         </a>
         ), and ingrown nails  (
         <a class="graphic graphic_picture graphicRef132187" href="/z/d/graphic/132187.html" rel="external">
          picture 16
         </a>
         ). Inflammatory nail diseases that almost exclusively affect children include parakeratosis pustulosa  (
         <a class="graphic graphic_picture graphicRef131767" href="/z/d/graphic/131767.html" rel="external">
          picture 9
         </a>
         ), nail lichen striatus  (
         <a class="graphic graphic_picture graphicRef95734" href="/z/d/graphic/95734.html" rel="external">
          picture 12
         </a>
         ), and idiopathic trachyonychia  (
         <a class="graphic graphic_picture graphicRef131778" href="/z/d/graphic/131778.html" rel="external">
          picture 15
         </a>
         ). (See
         <a class="local">
          'Inflammatory diseases'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infections
         </strong>
         – Distal subungual onychomycosis  (
         <a class="graphic graphic_picture graphicRef131788" href="/z/d/graphic/131788.html" rel="external">
          picture 17
         </a>
         ) is the most common type of dermatophyte nail infection in children. Viral diseases affecting the nails and periungual tissues include viral warts  (
         <a class="graphic graphic_picture graphicRef131807" href="/z/d/graphic/131807.html" rel="external">
          picture 18
         </a>
         ); herpetic whitlow  (
         <a class="graphic graphic_picture graphicRef131819" href="/z/d/graphic/131819.html" rel="external">
          picture 19
         </a>
         ); and hand, foot, and mouth disease (HFMD)-associated onychomadesis (nail shedding). Bacterial infections of the nail apparatus in children include acute paronychia  (
         <a class="graphic graphic_picture graphicRef132405" href="/z/d/graphic/132405.html" rel="external">
          picture 21
         </a>
         ) and blistering distal dactylitis  (
         <a class="graphic graphic_picture graphicRef85581 graphicRef85582 graphicRef85580" href="/z/d/graphic/85581.html" rel="external">
          picture 20A-C
         </a>
         ). (See
         <a class="local">
          'Infectious diseases'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tumors
         </strong>
         – Tumors of the nail apparatus are rare. Among them, subungual exostosis  (
         <a class="graphic graphic_picture graphicRef131994" href="/z/d/graphic/131994.html" rel="external">
          picture 22
         </a>
         ) is the most frequently seen in children. Other tumors include fibrokeratoma  (
         <a class="graphic graphic_picture graphicRef132362" href="/z/d/graphic/132362.html" rel="external">
          picture 23
         </a>
         ) and pyogenic granuloma. Longitudinal melanonychia affecting a single digit represents a nail matrix nevus  (
         <a class="graphic graphic_picture graphicRef131995" href="/z/d/graphic/131995.html" rel="external">
          picture 24
         </a>
         ) in most cases; nail melanoma is exceedingly rare in children. (See
         <a class="local">
          'Tumors'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Richert B, André J. Nail disorders in children: diagnosis and management. Am J Clin Dermatol 2011; 12:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piraccini BM, Starace M. Nail disorders in infants and children. Curr Opin Pediatr 2014; 26:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iglesias A, Tamayo L, Sosa-de-Martínez C, et al. Prevalence and nature of nail alterations in pediatric patients. Pediatr Dermatol 2001; 18:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tasia M, Lecerf P, Richert B, André J. Paediatric nail consultation in an academic centre in Belgium: a 10-year retrospective study. J Eur Acad Dermatol Venereol 2019; 33:1800.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Totri CR, Feldstein S, Admani S, et al. Epidemiologic Analysis of Onychomycosis in the San Diego Pediatric Population. Pediatr Dermatol 2017; 34:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Solís-Arias MP, García-Romero MT. Onychomycosis in children. A review. Int J Dermatol 2017; 56:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Berker D. Nail anatomy. Clin Dermatol 2013; 31:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Starace M, Alessandrini A, Piraccini BM. Nail Disorders in Children. Skin Appendage Disord 2018; 4:217.
          </a>
         </li>
         <li class="breakAll">
          Staufert Gutierrez D, Carugno P. Thumb sucking. In: StatPearls, StatPearls Publishing, 2023.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winebrake JP, Grover K, Halteh P, Lipner SR. Pediatric Onychophagia: A Survey-Based Study of Prevalence, Etiologies, and Co-Morbidities. Am J Clin Dermatol 2018; 19:887.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee DY. Chronic nail biting and irreversible shortening of the fingernails. J Eur Acad Dermatol Venereol 2009; 23:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Halteh P, Scher RK, Lipner SR. Onychophagia: A nail-biting conundrum for physicians. J Dermatolog Treat 2017; 28:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Berker DA, Richert B, Duhard E, et al. Retronychia: proximal ingrowing of the nail plate. J Am Acad Dermatol 2008; 58:978.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mello CDBF, Souza MDRE, Noriega LF, Chiacchio ND. Retronychia. An Bras Dermatol 2018; 93:707.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piraccini BM, Richert B, de Berker DA, et al. Retronychia in children, adolescents, and young adults: a case series. J Am Acad Dermatol 2014; 70:388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lencastre A, Iorizzo M, Caucanas M, et al. Topical steroids for the treatment of retronychia. J Eur Acad Dermatol Venereol 2019; 33:e320.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laird ME, Lo Sicco KI, Rich P. Conservative Treatment of Retronychia: A Retrospective Study of 25 Patients. Dermatol Surg 2019; 45:614.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sechi A, Zengarini C, Piraccini BM, et al. Treatment of retronychia: A systematic review and suggested treatment algorithm. Dermatol Ther 2022; 35:e15251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alessandrini A, Sechi A, Merli Y, et al. Intralesional steroid treatment for the intermediate stage of retronychia: A pilot study. Dermatol Ther 2020; 33:e14174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pourchot D, Bodemer C, Phan A, et al. Nail Psoriasis: A Systematic Evaluation in 313 Children with Psoriasis. Pediatr Dermatol 2017; 34:58.
          </a>
         </li>
         <li class="breakAll">
          Piraccini BM, Starace M. Nail psoriasis in special populations: Children, pregnant, elderly. In: Nail Psoriasis: From A to Z, 1st ed, Rigopoulos D, Tosti A (Eds), Springer International Publishing, 2014. p.131.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Mutairi N, Manchanda Y, Nour-Eldin O. Nail changes in childhood psoriasis: a study from Kuwait. Pediatr Dermatol 2007; 24:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mercy K, Kwasny M, Cordoro KM, et al. Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States. Pediatr Dermatol 2013; 30:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piraccini BM, Triantafyllopoulou I, Prevezas C, et al. Nail Psoriasis in Children: Common or Uncommon? Results from a 10-Year Double-Center Study. Skin Appendage Disord 2015; 1:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coronel L, Gouze H, Gudu T, et al. Prevalence of ultrasound and clinical findings suggestive of inflammatory arthritis in children with skin psoriasis. Rheumatology (Oxford) 2023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith RJ, Rubin AI. Pediatric nail disorders: a review. Curr Opin Pediatr 2020; 32:506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Starace M, Alessandrini A, Bruni F, Piraccini BM. Trachyonychia: a retrospective study of 122 patients in a period of 30 years. J Eur Acad Dermatol Venereol 2020; 34:880.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bardazzi F, Starace M, Bruni F, et al. Nail Psoriasis: An Updated Review and Expert Opinion on Available Treatments, Including Biologics. Acta Derm Venereol 2019; 99:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sutaria A, Pol D, Dalave K, et al. Onychoscopy of Nail Lesions in Dermatological Disorders: A Cross-Sectional Observational Study. Indian J Dermatol 2023; 68:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas L, Azad J, Takwale A. Management of nail psoriasis. Clin Exp Dermatol 2021; 46:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iorizzo M, Gioia Di Chiacchio N, Di Chiacchio N, et al. Intralesional steroid injections for inflammatory nail dystrophies in the pediatric population. Pediatr Dermatol 2023; 40:759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sticherling M, Nikkels AF, Hamza AM, et al. Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials. Am J Clin Dermatol 2023; 24:821.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bronckers IMGJ, Bruins FM, van Geel MJ, et al. Nail Involvement as a Predictor of Disease Severity in Paediatric Psoriasis: Follow-up Data from the Dutch ChildCAPTURE Registry. Acta Derm Venereol 2019; 99:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eichenfield LF, Paller AS, Tom WL, et al. Pediatric psoriasis: Evolving perspectives. Pediatr Dermatol 2018; 35:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tosti A, Peluso AM, Zucchelli V. Clinical features and long-term follow-up of 20 cases of parakeratosis pustulosa. Pediatr Dermatol 1998; 15:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chung BY, Choi YW, Kim HO, Park CW. Nail Dystrophy in Patients with Atopic Dermatitis and Its Association with Disease Severity. Ann Dermatol 2019; 31:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arslan Uku S, Demir B, Cicek D, Inan Yuksel E. Assessment of nail findings in children with atopic dermatitis. Clin Exp Dermatol 2021; 46:1511.
          </a>
         </li>
         <li class="breakAll">
          Shiohara T, Mizukawa Y. Lichen planus. In: Dermatology, 4th ed, Bolognia JL, Shaffer JV, Cerroni L (Eds), Elsevier, 2018.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chu DH, Rubin AI. Diagnosis and management of nail disorders in children. Pediatr Clin North Am 2014; 61:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goettmann S, Zaraa I, Moulonguet I. Nail lichen planus: epidemiological, clinical, pathological, therapeutic and prognosis study of 67 cases. J Eur Acad Dermatol Venereol 2012; 26:1304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pandhi D, Singal A, Bhattacharya SN. Lichen planus in childhood: a series of 316 patients. Pediatr Dermatol 2014; 31:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohandesi NA, Berry NA, Tollefson MM, et al. Pediatric lichen planus: A single-center retrospective review of 26 patients with follow up. Pediatr Dermatol 2023; 40:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tosti A, Piraccini BM, Cambiaghi S, Jorizzo M. Nail lichen planus in children: clinical features, response to treatment, and long-term follow-up. Arch Dermatol 2001; 137:1027.
          </a>
         </li>
         <li class="breakAll">
          Piraccini BM, Starace M. Nail disorders. In: Atlas of Pediatric Dermatoscopy, 1st ed, Micali G, Lacarrubba F, Stinco G, et al (Eds), Springer International Publishing, 2018. p.175.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakamura R, Broce AA, Palencia DP, et al. Dermatoscopy of nail lichen planus. Int J Dermatol 2013; 52:684.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friedman P, Sabban EC, Marcucci C, et al. Dermoscopic findings in different clinical variants of lichen planus. Is dermoscopy useful? Dermatol Pract Concept 2015; 5:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iorizzo M, Tosti A, Starace M, et al. Isolated nail lichen planus: An expert consensus on treatment of the classical form. J Am Acad Dermatol 2020; 83:1717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piraccini BM, Saccani E, Starace M, et al. Nail lichen planus: response to treatment and long term follow-up. Eur J Dermatol 2010; 20:489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iorizzo M. Nail lichen planus - a possible new indication for oral alitretinoin. J Eur Acad Dermatol Venereol 2016; 30:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alsenaid A, Eder I, Ruzicka T, et al. Successful treatment of nail lichen planus with alitretinoin: report of 2 cases and review of the literature. Dermatology 2014; 229:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mostafa WZ. Lichen planus of the nail: treatment with antimalarials. J Am Acad Dermatol 1989; 20:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Başak PY, Başak K. Generalized lichen planus in childhood: is dapsone an effective treatment modality? Turk J Pediatr 2002; 44:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheon DU, Ro YS, Kim JE. Treatment of nail lichen Striatus with Intralesional steroid injection: A case report and literature review. Dermatol Ther 2018; 31:e12713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim M, Jung HY, Eun YS, et al. Nail lichen striatus: report of seven cases and review of the literature. Int J Dermatol 2015; 54:1255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iorizzo M, Rubin AI, Starace M. Nail lichen striatus: Is dermoscopy useful for the diagnosis? Pediatr Dermatol 2019; 36:859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tosti A, Peluso AM, Misciali C, Cameli N. Nail lichen striatus: clinical features and long-term follow-up of five patients. J Am Acad Dermatol 1997; 36:908.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leung AKC, Leong KF, Barankin B. Lichen Striatus with Nail Involvement in a 6-Year-Old Boy. Case Rep Pediatr 2020; 2020:1494760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tosti A, Morelli R, Bardazzi F, Peluso AM. Prevalence of nail abnormalities in children with alopecia areata. Pediatr Dermatol 1994; 11:112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chelidze K, Lipner SR. Nail changes in alopecia areata: an update and review. Int J Dermatol 2018; 57:776.
          </a>
         </li>
         <li class="breakAll">
          Tosti A, Piraccini BM. Dermatological diseases. In: Nails, 3rd ed, Scher RK, Tosti A, Elewski BE, et al (Eds), Saunders, 2005.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leung AKC, Leong KF, Barankin B. Trachyonychia. J Pediatr 2020; 216:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ezekian B, Englum BR, Gilmore BF, et al. Onychocryptosis in the Pediatric Patient. Clin Pediatr (Phila) 2017; 56:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geizhals S, Lipner SR. Review of onychocryptosis: epidemiology, pathogenesis, risk factors, diagnosis and treatment. Dermatol Online J 2019; 25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eekhof JA, Van Wijk B, Knuistingh Neven A, van der Wouden JC. Interventions for ingrowing toenails. Cochrane Database Syst Rev 2012; :CD001541.
          </a>
         </li>
         <li class="breakAll">
          Chabchoub I, Litaiem N. Ingrown toenails. In: StatPearls, StatPearls Publishing, 2021.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta AK, Daigle D, Foley KA. The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations. J Eur Acad Dermatol Venereol 2015; 29:1039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gulgun M, Balci E, Karaoglu A, et al. Prevalence and risk factors of onychomycosis in primary school children living in rural and urban areas in Central Anatolia of Turkey. Indian J Dermatol Venereol Leprol 2013; 79:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vestergaard-Jensen S, Mansouri A, Jensen LH, et al. Systematic review of the prevalence of onychomycosis in children. Pediatr Dermatol 2022; 39:855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Song G, Zhang M, Liu W, Liang G. Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment. Mycoses 2023; 66:448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piraccini BM, Bruni F, Starace M. Onychomycosis in children. Expert Rev Dermatol 2012; 7:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leung LK, Harding J. A chemical mixer with dark-green nails. BMJ Case Rep 2015; 2015.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eichenfield LF, Friedlander SF. Pediatric Onychomycosis: The Emerging Role of Topical Therapy. J Drugs Dermatol 2017; 16:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nenoff P, Reinel D, Mayser P, et al. S1 Guideline onychomycosis. J Dtsch Dermatol Ges 2023; 21:678.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alfaro S DA, González F CG. [Pediatric onychomycosis: Update and management]. Rev Chil Pediatr 2020; 91:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friedlander SF, Chan YC, Chan YH, Eichenfield LF. Onychomycosis does not always require systemic treatment for cure: a trial using topical therapy. Pediatr Dermatol 2013; 30:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta AK, Mays RR, Versteeg SG, et al. Onychomycosis in children: Safety and efficacy of antifungal agents. Pediatr Dermatol 2018; 35:552.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tosti A, Piraccini BM. Warts of the nail unit: surgical and nonsurgical approaches. Dermatol Surg 2001; 27:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akdoğan N, Yıldırım SK, Kültür E, Evans SE. The effect of warts on quality of life in Turkish pediatric patients. Turk J Pediatr 2020; 62:1028.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldman RD. Duct tape for warts in children: Should nature take its course? Can Fam Physician 2019; 65:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agrawal I, Singh BBSTP, Kar BR. Dermoscopic Findings of Recurrent Herpetic Whitlow in a Child. Dermatol Pract Concept 2022; 12:e2022052.
          </a>
         </li>
         <li class="breakAll">
          Betz D, Fane K. Herpetic whitlow. In: StatPearls, StatPearls Publishing, 2021.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gao L, Zou G, Liao Q, et al. Spectrum of Enterovirus Serotypes Causing Uncomplicated Hand, Foot, and Mouth Disease and Enteroviral Diagnostic Yield of Different Clinical Samples. Clin Infect Dis 2018; 67:1729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akpolat ND, Karaca N. Nail changes secondary to hand-foot-mouth disease. Turk J Pediatr 2016; 58:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Apalla Z, Sotiriou E, Pikou O, et al. Onychomadesis after hand-foot-and-mouth disease outbreak in northern Greece: case series and brief review of the literature. Int J Dermatol 2015; 54:1039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuehnel NA, Thach S, Thomas DG. Onychomadesis as a Late Complication of Hand-Foot-Mouth Disease: A Case Series Shedding Light on Nail Shedding. Pediatr Emerg Care 2017; 33:e122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xavier JPO, Junior JCCX. Onychomadesis secondary to hand-foot-and-mouth disease: report of two cases. An Bras Dermatol 2020; 95:266.
          </a>
         </li>
         <li class="breakAll">
          Anjaneyan G, Kaliyadan F. Blistering distal dactylitis. In: StatPearls, StatPearls Publishing, 2021.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang LW, Wang WJ, Chen T. Blistering distal dactylitis. CMAJ 2022; 194:E167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen R, Levy C, Cohen J, et al. [Diagnostic of group A streptococcal blistering distal dactylitis]. Arch Pediatr 2014; 21 Suppl 2:S93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fretzayas A, Moustaki M, Tsagris V, et al. MRSA blistering distal dactylitis and review of reported cases. Pediatr Dermatol 2011; 28:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rigopoulos D, Larios G, Gregoriou S, Alevizos A. Acute and chronic paronychia. Am Fam Physician 2008; 77:339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boull CL, Gardeen S, Abdali T, et al. Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study. J Am Acad Dermatol 2021; 84:1554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKean AR, Williams GJ, Macneal P, et al. Paediatric paronychia: A single centre retrospective, microbiological analysis and national survey. J Plast Reconstr Aesthet Surg 2022; 75:2387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DaCambra MP, Gupta SK, Ferri-de-Barros F. Subungual exostosis of the toes: a systematic review. Clin Orthop Relat Res 2014; 472:1251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li H, Li H, Qi X, et al. Clinical diagnosis and treatment of subungual exostosis in children. Front Pediatr 2022; 10:1075089.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piccolo V, Argenziano G, Alessandrini AM, et al. Dermoscopy of Subungual Exostosis: A Retrospective Study of 10 Patients. Dermatology 2017; 233:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Göktay F, Atış G, Güneş P, et al. Subungual exostosis and subungual osteochondromas: a description of 25 cases. Int J Dermatol 2018; 57:872.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wollina U, Baran R, Schönlebe J. Dystrophy of the Great Toenail by Subungual Exostosis and Hyperostosis: Three Case Reports with Different Clinical Presentations. Skin Appendage Disord 2016; 1:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Starace M, Rubin AI, Di Chiacchio NG, et al. Diagnosis and surgical treatment of benign nail unit tumors. J Dtsch Dermatol Ges 2023; 21:116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baran R, Richert B. Common nail tumors. Dermatol Clin 2006; 24:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Altman DA, Griner JM, Faria DT. Acquired digital fibrokeratoma. Cutis 1994; 54:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ballan A, Zeinaty P, Tomb R, et al. Acquired ungual fibrokeratoma: a systematic review of the literature. Int J Dermatol 2021; 60:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alessandrini A, Bruni F, Starace M, Piraccini BM. Periungual Pyogenic Granuloma: The Importance of the Medical History. Skin Appendage Disord 2016; 1:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Provvidenziale L, Russo F, Taddeucci P, Rubegni P. Treatment of childhood pyogenic granuloma of the nail bed with topical timolol. Dermatol Ther 2020; 33:e13710.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piraccini BM, Alessandrini A, Dika E, et al. Topical propranolol 1% cream for pyogenic granulomas of the nail: open-label study in 10 patients. J Eur Acad Dermatol Venereol 2016; 30:901.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wine Lee L, Goff KL, Lam JM, et al. Treatment of pediatric pyogenic granulomas using β-adrenergic receptor antagonists. Pediatr Dermatol 2014; 31:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frommer SA, Leathers KO. Treatment of a Large Nail-Bed Pyogenic Granuloma with Topical Timolol. J Am Podiatr Med Assoc 2023; 113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tritton SM, Smith S, Wong LC, et al. Pyogenic granuloma in ten children treated with topical imiquimod. Pediatr Dermatol 2009; 26:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Starace M, Alessandrini A, Brandi N, Piraccini BM. Use of Nail Dermoscopy in the Management of Melanonychia: Review. Dermatol Pract Concept 2019; 9:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee J, Bae JH, Oh SJ, et al. Clinical and histopathologic features of pediatric longitudinal melanonychia: A multicenter retrospective study. J Am Acad Dermatol 2023; 88:1393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tosti A, Piraccini BM, de Farias DC. Dealing with melanonychia. Semin Cutan Med Surg 2009; 28:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stefanaki C, Soura E, Sgouros D, et al. Nail matrix naevi in children: a prospective study. J Eur Acad Dermatol Venereol 2020; 34:e203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tosti A, Baran R, Morelli R, et al. Progressive fading of longitudinal melanonychia due to a nail matrix melanocytic nevus in a child. Arch Dermatol 1994; 130:1076.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maddy AJ, Tosti A. Spontaneous Regression of a Nail Matrix Melanocytic Nevus in a Child. Pediatr Dermatol 2017; 34:e254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pham F, Boespflug A, Duru G, et al. Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society. J Am Acad Dermatol 2022; 87:551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khatri SS, Wang M, Harms KL, et al. Subungual atypical lentiginous melanocytic proliferations in children and adolescents: A clinicopathologic study. J Am Acad Dermatol 2018; 79:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conway J, Bellet JS, Rubin AI, Lipner SR. Adult and Pediatric Nail Unit Melanoma: Epidemiology, Diagnosis, and Treatment. Cells 2023; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Di Chiacchio N, Ruben BS, Loureiro WR. Longitudinal melanonychias. Clin Dermatol 2013; 31:594.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 126413 Version 4.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21348541" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Nail disorders in children: diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24886951" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Nail disorders in infants and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11358547" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Prevalence and nature of nail alterations in pediatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30835872" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Paediatric nail consultation in an academic centre in Belgium: a 10-year retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27699839" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Epidemiologic Analysis of Onychomycosis in the San Diego Pediatric Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27612431" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Onychomycosis in children. A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24079579" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Nail anatomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30410888" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Nail Disorders in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30410888" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Nail Disorders in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30171499" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Pediatric Onychophagia: A Survey-Based Study of Prevalence, Etiologies, and Co-Morbidities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18429981" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Chronic nail biting and irreversible shortening of the fingernails.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27387832" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Onychophagia: A nail-biting conundrum for physicians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18375016" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Retronychia: proximal ingrowing of the nail plate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30156621" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Retronychia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24438963" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Retronychia in children, adolescents, and young adults: a case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30932220" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Topical steroids for the treatment of retronychia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30346320" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Conservative Treatment of Retronychia: A Retrospective Study of 25 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34877747" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Treatment of retronychia: A systematic review and suggested treatment algorithm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32779351" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Intralesional steroid treatment for the intermediate stage of retronychia: A pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27873356" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Nail Psoriasis: A Systematic Evaluation in 313 Children with Psoriasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27873356" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Nail Psoriasis: A Systematic Evaluation in 313 Children with Psoriasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17300641" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Nail changes in childhood psoriasis: a study from Kuwait.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23360462" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27172521" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Nail Psoriasis in Children: Common or Uncommon? Results from a 10-Year Double-Center Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37540167" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Prevalence of ultrasound and clinical findings suggestive of inflammatory arthritis in children with skin psoriasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32692049" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Pediatric nail disorders: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31923322" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Trachyonychia: a retrospective study of 122 patients in a period of 30 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30521057" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Nail Psoriasis: An Updated Review and Expert Opinion on Available Treatments, Including Biologics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37151277" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Onychoscopy of Nail Lesions in Dermatological Disorders: A Cross-Sectional Observational Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32741010" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Management of nail psoriasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36939031" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Intralesional steroid injections for inflammatory nail dystrophies in the pediatric population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37341961" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30206638" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Nail Involvement as a Predictor of Disease Severity in Paediatric Psoriasis: Follow-up Data from the Dutch ChildCAPTURE Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29314219" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Pediatric psoriasis: Evolving perspectives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9720686" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Clinical features and long-term follow-up of 20 cases of parakeratosis pustulosa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33911559" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Nail Dystrophy in Patients with Atopic Dermatitis and Its Association with Disease Severity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34089190" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Assessment of nail findings in children with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34089190" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Assessment of nail findings in children with atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24636647" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Diagnosis and management of nail disorders in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22049906" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Nail lichen planus: epidemiological, clinical, pathological, therapeutic and prognosis study of 67 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23627802" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Lichen planus in childhood: a series of 316 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36373243" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Pediatric lichen planus: A single-center retrospective review of 26 patients with follow up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11493095" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Nail lichen planus in children: clinical features, response to treatment, and long-term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11493095" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Nail lichen planus in children: clinical features, response to treatment, and long-term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23432149" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Dermatoscopy of nail lichen planus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26693092" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Dermoscopic findings in different clinical variants of lichen planus. Is dermoscopy useful?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32112995" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Isolated nail lichen planus: An expert consensus on treatment of the classical form.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20400392" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Nail lichen planus: response to treatment and long term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25439242" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Nail lichen planus - a possible new indication for oral alitretinoin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25322730" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Successful treatment of nail lichen planus with alitretinoin: report of 2 cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2915064" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Lichen planus of the nail: treatment with antimalarials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12458814" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Generalized lichen planus in childhood: is dapsone an effective treatment modality?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30397987" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Treatment of nail lichen Striatus with Intralesional steroid injection: A case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26474189" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Nail lichen striatus: report of seven cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31359464" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Nail lichen striatus: Is dermoscopy useful for the diagnosis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9204052" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Nail lichen striatus: clinical features and long-term follow-up of five patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32047689" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Lichen Striatus with Nail Involvement in a 6-Year-Old Boy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8041648" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Prevalence of nail abnormalities in children with alopecia areata.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29318582" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Nail changes in alopecia areata: an update and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29318582" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Nail changes in alopecia areata: an update and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31542154" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Trachyonychia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27941086" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Onychocryptosis in the Pediatric Patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31738836" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Review of onychocryptosis: epidemiology, pathogenesis, risk factors, diagnosis and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22513901" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Interventions for ingrowing toenails.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22513901" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Interventions for ingrowing toenails.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25413984" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24177609" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Prevalence and risk factors of onychomycosis in primary school children living in rural and urban areas in Central Anatolia of Turkey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36130720" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Systematic review of the prevalence of onychomycosis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36707404" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Onychomycosis in children
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26040827" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : A chemical mixer with dark-green nails.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28300851" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37212291" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : S1 Guideline onychomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32730424" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : [Pediatric onychomycosis: Update and management].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23278851" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Onychomycosis does not always require systemic treatment for cure: a trial using topical therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29943838" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Onychomycosis in children: Safety and efficacy of antifungal agents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11277888" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Warts of the nail unit: surgical and nonsurgical approaches.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33372442" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : The effect of warts on quality of life in Turkish pediatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31088871" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Duct tape for warts in children: Should nature take its course?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35646468" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Dermoscopic Findings of Recurrent Herpetic Whitlow in a Child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35646468" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Dermoscopic Findings of Recurrent Herpetic Whitlow in a Child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29688329" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Spectrum of Enterovirus Serotypes Causing Uncomplicated Hand, Foot, and Mouth Disease and Enteroviral Diagnostic Yield of Different Clinical Samples.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28266194" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Nail changes secondary to hand-foot-mouth disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25772385" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Onychomadesis after hand-foot-and-mouth disease outbreak in northern Greece: case series and brief review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29095779" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Onychomadesis as a Late Complication of Hand-Foot-Mouth Disease: A Case Series Shedding Light on Nail Shedding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32165023" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Onychomadesis secondary to hand-foot-and-mouth disease: report of two cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32165023" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Onychomadesis secondary to hand-foot-and-mouth disease: report of two cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35131755" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Blistering distal dactylitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25456688" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : [Diagnostic of group A streptococcal blistering distal dactylitis].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21438916" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : MRSA blistering distal dactylitis and review of reported cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18297959" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Acute and chronic paronychia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32682884" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35589547" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Paediatric paronychia: A single centre retrospective, microbiological analysis and national survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24146360" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Subungual exostosis of the toes: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36568424" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Clinical diagnosis and treatment of subungual exostosis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28482347" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Dermoscopy of Subungual Exostosis: A Retrospective Study of 10 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29704255" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Subungual exostosis and subungual osteochondromas: a description of 25 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27386469" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Dystrophy of the Great Toenail by Subungual Exostosis and Hyperostosis: Three Case Reports with Different Clinical Presentations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36808456" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Diagnosis and surgical treatment of benign nail unit tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16798427" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Common nail tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7956341" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Acquired digital fibrokeratoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33107051" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Acquired ungual fibrokeratoma: a systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27386461" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Periungual Pyogenic Granuloma: The Importance of the Medical History.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32472650" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Treatment of childhood pyogenic granuloma of the nail bed with topical timolol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25708373" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Topical propranolol 1% cream for pyogenic granulomas of the nail: open-label study in 10 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24138457" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Treatment of pediatric pyogenic granulomas usingβ-adrenergic receptor antagonists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36905620" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Treatment of a Large Nail-Bed Pyogenic Granuloma with Topical Timolol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19706086" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Pyogenic granuloma in ten children treated with topical imiquimod.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30775147" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Use of Nail Dermoscopy in the Management of Melanonychia: Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36841337" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Clinical and histopathologic features of pediatric longitudinal melanonychia: A multicenter retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19341943" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Dealing with melanonychia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31850539" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Nail matrix naevi in children: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8053713" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Progressive fading of longitudinal melanonychia due to a nail matrix melanocytic nevus in a child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28804956" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Spontaneous Regression of a Nail Matrix Melanocytic Nevus in a Child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35104588" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29601937" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Subungual atypical lentiginous melanocytic proliferations in children and adolescents: A clinicopathologic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36980308" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Adult and Pediatric Nail Unit Melanoma: Epidemiology, Diagnosis, and Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24079589" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Longitudinal melanonychias.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
